SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-028594
Filing Date
2018-04-30
Accepted
2018-04-30 16:37:30
Documents
5
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A a18-2832_2defa14a.htm DEFA14A 32291
2 GRAPHIC g28322bci001.gif GRAPHIC 53658
3 GRAPHIC g28322bci002.gif GRAPHIC 83336
4 GRAPHIC g28322bci003.gif GRAPHIC 32194
5 GRAPHIC g28322bci004.gif GRAPHIC 4009
  Complete submission text file 0001104659-18-028594.txt   272286
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36562 | Film No.: 18790454
SIC: 2834 Pharmaceutical Preparations